Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 3

1(20.0%)

Phase 1

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Phase 3(1)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07423156Phase 3Not Yet Recruiting

Tranexamic Acid vs Vasopressin in Placenta Previa Trial

Role: lead

NCT04228627Phase 4Completed

Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

Role: collaborator

NCT07334587Not ApplicableEnrolling By Invitation

Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

Role: lead

NCT07140627Phase 1Completed

COMPARISON OF BUPIVACAINE WITH AND WITHOUT DEXMEDETOMIDINE IN CAUDAL BLOCK AMONG CHILDREN UNDERGOING INGUINAL HERNIOTOMY

Role: lead

NCT06820502Not ApplicableActive Not Recruiting

OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA

Role: lead

All 5 trials loaded